How Retatrutide Compares The table below provides a high-level comparison of retatrutide Phase 2 results against approved drugs' Phase 3 results
The arithmetic is the same for every peptide and is worth doing by hand once so the calculator output can be sanity-checked
$12.00 116 in stock Retatrutide, a GLP-1/GIP/GCGR receptor agonist, significantly lowers blood gl
Currently in clinical development by Eli Lilly, retatrutide earned the nickname triple G because it mimics the action of three key metabolic hormones: GLP-1, GIP, and glucagon
These findings were complemented by SELECT [18], which demonstrated kidney benefit in non-diabetic individuals with overweight or obesity and established cardiovascular disease, positioning semaglutide as a benchmark GLP-1 receptor agonist for kidney protection across metabolic phenotypes
Methionine is an amino acid that helps prevent excess fat buildup in the liver and body